World's Best Scientists 2026 revealed!
Stuart J. Connolly

Stuart J. Connolly

Award Badge
Medicine
Canada
2023

D-Index & Metrics

Medicine

D-Index
157
Citations
127666
World Ranking
870
National Ranking
29

Research.com Recognitions

  • 2023 - Research.com Medicine in Canada Leader Award

Overview

Stuart J. Connolly was affiliated with McMaster University in Canada and contributed extensively to the field of Medicine, with a primary focus on Cardiology and Cardiovascular Medicine. Their work spanned several important subfields, including Epidemiology, Internal Medicine, Neurology, and Economics and Econometrics. Over the course of their career, they concentrated on key topics such as Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments, Venous Thromboembolism Diagnosis and Management, Acute Ischemic Stroke Management, Antiplatelet Therapy and Cardiovascular Diseases, Intracerebral and Subarachnoid Hemorrhage Research, and Cardiac Electrophysiology and Arrhythmias.

Connolly published research in several well-known medical journals. The most frequent publication venues included Circulation (17 publications), European Heart Journal (13 publications), Journal of the American College of Cardiology (10 publications), Stroke (10 publications), and New England Journal of Medicine (6 publications).

Notable papers authored or co-authored by Connolly covered topics central to stroke prevention, anticoagulant safety, and stroke risk associated with atrial fibrillation. Some recent examples are:

  • Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation, 2022, New England Journal of Medicine
  • Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke, 2021, New England Journal of Medicine
  • Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation, 2023, New England Journal of Medicine
  • Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study, 2022, The Lancet
  • Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials, 2023, Circulation

Frequent collaborators in Connolly's research included Jeff S. Healey (51 co-authored works), John W. Eikelboom (49), Alexander P. Benz (42), William F. McIntyre (39), and Lars Wallentin (26).

Best Publications

  • Dabigatran versus warfarin in patients with atrial fibrillation

    Stuart J. Connolly;Michael D. Ezekowitz;John Eikelboom;Jonas Oldgren

  • Apixaban in Patients with Atrial Fibrillation

    Stuart J. Connolly;John Eikelboom;Campbell Joyner;Hans-Christoph Diener

  • Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

    Stuart J. Connolly;Janice Pogue;Robert G. Hart;Stefan H. Hohnloser

  • Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.

    S Connolly;J Pogue;R Hart

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • Subclinical Atrial Fibrillation and the Risk of Stroke

    Jeff S. Healey;Stuart J. Connolly;Michael R. Gold;Carsten W. Israel

  • Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure

    Anthony S. L. Tang;George A. Wells;Mario Talajic;Malcolm O. Arnold

  • Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

    Stuart J. Connolly;Michael Gent;Robin S. Roberts;Paul Dorian

  • Rhythm control versus rate control for atrial fibrillation and heart failure

    Denis Roy;Mario Talajic;Stanley Nattel;D. George Wyse

  • Prophylactic Use of an Implantable Cardioverter-Defibrillator After Acute Myocardial Infarction

    Stefan H. Hohnloser;Karl Heinz Kuck;Paul Dorian;Robin S. Roberts

  • Embolic strokes of undetermined source: the case for a new clinical construct

    Robert G. Hart;Hans Christoph Diener;Shelagh B. Coutts;J. Donald Easton

  • Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

    John W. Eikelboom;Stuart J. Connolly;Martina Brueckmann;Christopher B. Granger

  • Amiodarone to Prevent Recurrence of Atrial Fibrillation

    Denis Roy;Mario Talajic;Paul Dorian;Stuart Connolly

  • Canadian atrial fibrillation anticoaguiation (CAFA) study

    Stuart J. Connolly;Andreas Laupacis;Michael Gent;Robin S. Roberts

  • Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

    John W. Eikelboom;Lars Wallentin;Stuart J. Connolly;Mike Ezekowitz

  • Effect of dronedarone on cardiovascular events in atrial fibrillation.

    Stefan H. Hohnloser;Martin van Eickels;Christophe Gaudin;Richard L. Page

  • Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: An analysis of the RE-LY trial

    Lars Wallentin;Salim Yusuf;Michael D Ezekowitz;Marco Alings

  • Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials

    S. J. Connolly;A. P. Hallstrom;R. Cappato;E. B. Schron

  • Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT

    John A Cairns;Stuart J Connolly;Robin Roberts;Michael Gent

  • Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome.

    Christian Guilleminault;Stuart J. Connolly;Roger A. Winkle

Frequent Co-Authors

Salim Yusuf
Salim Yusuf McMaster University
John W. Eikelboom
John W. Eikelboom Population Health Research Institute
Jeff S. Healey
Jeff S. Healey Population Health Research Institute
Lars Wallentin
Lars Wallentin Uppsala University
Stefan H. Hohnloser
Stefan H. Hohnloser Goethe University Frankfurt
Michael D. Ezekowitz
Michael D. Ezekowitz Lankenau Institute for Medical Research
Carlos A. Morillo
Carlos A. Morillo University of Calgary
Robert G. Hart
Robert G. Hart Population Health Research Institute
Paul Dorian
Paul Dorian University of Toronto
Michael Gent
Michael Gent McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a career in Medicine or related fields in the USA, various online degrees can broaden your options and enhance your expertise. These flexible programs allow you to balance work, study, and personal life while advancing professionally.

Interested in healthcare leadership? Explore the online mha programs affordable to develop management and administrative skills vital for hospital or clinic operations.

If your goal is a clinical or nursing leadership role, look into cheap online dnp programs that prepare registered nurses for the highest practice levels.

Pharmacy professionals can advance through 3 year online pharmd programs designed for accelerated, flexible learning, helping you become a Doctor of Pharmacy in less time.

For those fascinated by data and healthcare technology, healthcare informatics degree programs offer training in managing healthcare information systems—a rapidly growing field bridging tech and patient care.

These pathways offer affordability, flexibility, and strong employment prospects—making them excellent alternatives or complements to traditional medical degrees.

Best Scientists Citing Stuart J. Connolly

Recently Published Articles